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Bone morphogenetic protein-2 (BMP-2) is widely used in orthopedic surgery and bone 
tissue engineering because of its strong osteogenic activity. However, BMP-2 treatments have 
several drawbacks and alternatives are being explored. Since BMP-6 has been demonstrated to 
be more osteoinductive, its use, either alone or together with other cytokines, might be an 
interesting option.   
We have compared the effect of BMP-2, BMP-6, or insulin-like growth factor-1 (IGF-1), 
either alone or in combination. MC3T3-E1 cells were treated with IGF-1 and/or of BMP-2 or -6 
and the expression of osteogenic genes, proliferation and alkaline phosphatase (ALP) activity in 
vitro were analyzed. The results showed that IGF-1 greatly enhanced the BMP-induced 
osteogenic differentiation of these cells and that the ALP activity in the cultures was higher when 
the combination was made with BMP-6 than with BMP-2. Other in vitro experiments showed 
that the osteogenic effect of these combinations can be modulated controlling the sequential 
administration of the growth factors. 
Furthermore, we have tested the osteogenic potential of these treatments in vivo by 
loading them onto absorbable collagen sponges which were implanted into an ectopic bone 
formation model in rats. These experiments revealed that only BMP-6 was able to induce bone 
formation at the used dose and that the addition of IGF-1 contributed to an increase of the 
mineralization in the implants.  
Hence, the combination of BMP-6 with IGF-1 might be a better alternative than BMP-2 
for orthopedic surgery and bone tissue engineering approaches with potential application 
through using controlled delivery systems.  
 
